Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Jul;21(7):694-704.
doi: 10.6004/jnccn.2023.0035.

NCCN Guidelines® Insights: Biliary Tract Cancers, Version 2.2023

Affiliations

NCCN Guidelines® Insights: Biliary Tract Cancers, Version 2.2023

Al B Benson et al. J Natl Compr Canc Netw. 2023 Jul.

Abstract

In 2023, the NCCN Guidelines for Hepatobiliary Cancers were divided into 2 separate guidelines: Hepatocellular Carcinoma and Biliary Tract Cancers. The NCCN Guidelines for Biliary Tract Cancers provide recommendations for the evaluation and comprehensive care of patients with gallbladder cancer, intrahepatic cholangiocarcinoma, and extrahepatic cholangiocarcinoma. The multidisciplinary panel of experts meets at least on an annual basis to review requests from internal and external entities as well as to evaluate new data on current and emerging therapies. These Guidelines Insights focus on some of the recent updates to the NCCN Guidelines for Biliary Tract Cancers as well as the newly published section on principles of molecular testing.

PubMed Disclaimer

Similar articles

  • Modification and implementation of NCCN guidelines on hepatobiliary cancers in the Middle East and North Africa region.
    Yusuf MA, Kapoor VK, Kamel RR, Kazmi A, Uddin N, Masood N, Al-Abdulkareem A; MENA Hepatobiliary Cancer Regional Guidelines Committee. Yusuf MA, et al. J Natl Compr Canc Netw. 2010 Jul;8 Suppl 3:S36-40. doi: 10.6004/jnccn.2010.0123. J Natl Compr Canc Netw. 2010. PMID: 20697130
  • Biliary tract cancer.
    Søreide K, Dopazo C, Berrevoet F, Carrion-Alvarez L, Diaz-Nieto R, Andersson B, Stättner S; joint ESSO-EAHPBA-UEMS core curriculum working group. Søreide K, et al. Eur J Surg Oncol. 2025 Jun;51(6):108489. doi: 10.1016/j.ejso.2024.108489. Epub 2024 Jun 15. Eur J Surg Oncol. 2025. PMID: 38902180 Review.
  • Hepatobiliary cancers, version 2.2014.
    Benson AB 3rd, D'Angelica MI, Abrams TA, Are C, Bloomston PM, Chang DT, Clary BM, Covey AM, Ensminger WD, Iyer R, Kelley RK, Linehan D, Malafa MP, Meranze SG, Park JO, Pawlik T, Posey JA, Scaife C, Schefter T, Sigurdson ER, Tian GG, Vauthey JN, Venook AP, Yen Y, Zhu AX, Hoffmann KG, McMillian NR, Sundar H. Benson AB 3rd, et al. J Natl Compr Canc Netw. 2014 Aug;12(8):1152-82. doi: 10.6004/jnccn.2014.0112. J Natl Compr Canc Netw. 2014. PMID: 25099447
  • Biliary tract cancer.
    Curley SA. Curley SA. Cancer Treat Res. 1997;90:273-307. doi: 10.1007/978-1-4615-6165-1_15. Cancer Treat Res. 1997. PMID: 9367089 Review. No abstract available.
  • [Clinical relevance of the new S3 guideline on hepatocellular carcinoma and biliary tract cancer for practitioners].
    Voesch S, Bitzer M, Malek N. Voesch S, et al. Radiologe. 2022 Mar;62(3):200-204. doi: 10.1007/s00117-022-00970-3. Epub 2022 Feb 11. Radiologe. 2022. PMID: 35147708 Review. German.

Cited by

MeSH terms

LinkOut - more resources